167 related articles for article (PubMed ID: 16500024)
1. New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.
Medina-Arana V; Barrios Y; Fernández-Peralta A; Herrera M; Chinea N; Lorenzo N; Jiménez A; Martín-López JV; González-Hermoso F; Salido E; González-Aguilera JJ
Cancer Lett; 2006 Dec; 244(2):268-73. PubMed ID: 16500024
[TBL] [Abstract][Full Text] [Related]
2. Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome.
Menéndez M; Castellví-Bel S; Pineda M; de Cid R; Muñoz J; González S; Teulé A; Balaguer F; Ramón y Cajal T; Reñé JM; Blanco I; Castells A; Capellà G
Clin Genet; 2010 Aug; 78(2):186-90. PubMed ID: 20095990
[TBL] [Abstract][Full Text] [Related]
3. The frequency of Muir-Torre syndrome among Lynch syndrome families.
South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
[TBL] [Abstract][Full Text] [Related]
4. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
5. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
[TBL] [Abstract][Full Text] [Related]
6. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
9. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
Ripa RS; Katballe N; Wikman FP; Jäger AC; Bernstein I; Orntoft T; Schwartz M; Nielsen FC; Bisgaard ML
Mutat Res; 2005 Feb; 570(1):89-96. PubMed ID: 15680406
[TBL] [Abstract][Full Text] [Related]
10. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
[TBL] [Abstract][Full Text] [Related]
11. Origins and prevalence of the American Founder Mutation of MSH2.
Clendenning M; Baze ME; Sun S; Walsh K; Liyanarachchi S; Fix D; Schunemann V; Comeras I; Deacon M; Lynch JF; Gong G; Thomas BC; Thibodeau SN; Lynch HT; Hampel H; de la Chapelle A
Cancer Res; 2008 Apr; 68(7):2145-53. PubMed ID: 18381419
[TBL] [Abstract][Full Text] [Related]
12. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
[TBL] [Abstract][Full Text] [Related]
13. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y;
Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554
[TBL] [Abstract][Full Text] [Related]
14. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
[TBL] [Abstract][Full Text] [Related]
15. High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.
Chong G; Jarry J; Marcus V; Thiffault I; Winocour S; Monczak Y; Drouin R; Latreille J; Australie K; Bapat B; Gordon PH; Giguère Y; Gologan A; Galiatsatos P; Jass JR; Wong N; Zaor S; Palma L; Kasprzak L; Tischkowitz M; Foulkes WD
Hum Mutat; 2009 Aug; 30(8):E797-812. PubMed ID: 19459153
[TBL] [Abstract][Full Text] [Related]
16. The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.
Sun S; Greenwood CM; Thiffault I; Hamel N; Chong G; Foulkes WD
J Med Genet; 2005 Oct; 42(10):766-8. PubMed ID: 16199548
[TBL] [Abstract][Full Text] [Related]
17. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
[TBL] [Abstract][Full Text] [Related]
18. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in an MSH2 gene mutation carrier.
Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN
Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127
[TBL] [Abstract][Full Text] [Related]
20. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Vasen HF
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
